Skip to main content
Clinical Trials/NCT07058389
NCT07058389RecruitingNot Applicable

Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia: a Pilot Study.

Centre Hospitalier Universitaire de Saint Etienne1 site in 1 country45 target enrollmentStarted: October 7, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
45
Locations
1
Primary Endpoint
Self-evaluation of negative symptoms (SNS) questionnaire

Study Overview

Brief Summary

Physical activity appears to be a novel and original adjunctive therapeutic approach in the management of patients with schizophrenia. It may help reduce schizophrenic symptoms, act as a pro-cognitive therapy, improve quality of life, and reduce cardiovascular comorbidities. Moreover, some evidence suggests that physical activity practiced in a natural environment has even more positive effects on mental health compared to physical activity carried out indoors or in urban settings. Indeed, greater exposure to greenery is associated with a better perception of general health and with reduced levels of cortisol, anxiety, and depression. No study has yet attempted to examine the impact of physical activity in green (outdoor) spaces compared to indoor physical activity on the negative symptoms of patients suffering from schizophrenia. The aim of this study is therefore to test this hypothesis.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with schizophrenia, aged 18 to 55 years
  • •Having persistent negative symptoms (SNS), negative symptoms self-assessment scale > 7
  • •Regularly monitored in the psychiatry department.
  • •Have no medical contraindications to physical activity
  • •Subject affiliated with or entitled to a social security system.
  • •Subject having received informed information about the study and having co-signed, with the investigator, consent to participate in the study.
  • •Male or female.

Exclusion Criteria

  • •Patient unsuitable for study in the opinion of the investigator
  • •Any subject with chronic joint pathologies (example: repeated sprains, patellar or ligament problems) or cardiac pathologies.
  • •Any subject presenting chronic or central neurological pathologies.
  • •Any subject deprived of liberty or subject to legal protection
  • •Excessive consumption of alcohol (> 14 glasses per week) or caffeinated drinks (> 400 mg of coffee per day).
  • •Pregnant women.
  • •Subject unable to understand the purpose and conditions of the study, unable to give consent.

Arms & Interventions

INT group

Experimental

8-week indoor physical activity program (in a gymnasium)

Intervention: 8-week indoor physical activity program (Other)

EXT group

Experimental

8-week outdoor physical activity program

Intervention: 8-week outdoor physical activity program (Other)

TEM group

No Intervention

Without physical activiy program (no change in routine)

Outcomes

Primary Outcomes

Self-evaluation of negative symptoms (SNS) questionnaire

Time Frame: Weeks 2, 10 and 22

The primary outcome will be the evolution of negative symtoms, assessed using the Self-evaluation of negative symptoms (SNS) questionnaire. The total SNS score ranges from 0 to 40, where higher scores indicate greater severity of negative symptoms.

Secondary Outcomes

  • Balance(Weeks 2, 10 and 22.)
  • Clinical global Impression (CGI) scale(Weeks 2, 10 and 22)
  • Personal and social performance (PSP) scale(Weeks 2, 10 and 22)
  • Subjective Scale to Investigate Cognition in Schizophrenia (SSTICS)(Weeks 2, 10 and 22.)
  • VO2 max(Weeks 2, 10 and 22.)
  • Flexibility(Weeks 2, 10 and 22.)
  • Maximum force(Weeks 2, 10 and 22.)
  • Spatio-temporal coordination(Weeks 2, 10 and 22.)
  • IPAQ questionnaire(Weeks 2, 10 and 22.)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials